Lumeran, Jerald Kurt D.
HRN: 21-74-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/16/2025
11/23/2025
IV DRIP
565mg
Q6
PCAP C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes